Output details
1 - Clinical Medicine
Queen's University Belfast
Return to search
Output 0 of 0 in the submission
Article title
A phase I study of the Heat Shock Protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced, solid tumours.
Type
D - Journal article
Title of journal
Clinical Cancer Research
Article number
-
Volume number
17
Issue number
6
First page of article
1561
ISSN of journal
1078-0432
Year of publication
2011
URL
-
Number of additional authors
12
Additional information
The author made a substantial contribution to the conception and design of the study, to the organisation of the conduct of the study, to carrying out the study (including acquisition of study data), to the analysis and interpretation of the study data. The author helped draft the output and critiqued the output for important intellectual content.
Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
50
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-
